Sarepta therapeutics announces inducement grants under nasdaq listing rule 5635(c)(4)

Cambridge, mass., dec. 31, 2020 (globe newswire) -- sarepta therapeutics, inc. (nasdaq:srpt), the leader in precision genetic medicine for rare diseases, granted equity awards on december 31, 2020 that were previously approved by the compensation committee of its board of directors under sarepta's 2014 employment commencement incentive plan, as a material inducement to employment to 11 individuals hired by sarepta in december 2020. the equity awards were approved in accordance with nasdaq listing rule 5635(c)(4).
SRPT Ratings Summary
SRPT Quant Ranking